New dosage regimens for HES during intensive leukapheresis.
D004305:Dose-Response Relationship, Drug; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000627:therapeutic use*; D010956:Plasmapheresis; D013213:Starch / Q000031:analogs & derivatives*
D006895:Hydroxyethyl Starch Derivatives; D013213:Starch